-
Management strategies for hyperglycemia associated with the α-selective PI3K inhibitor alpelisib for the treatment of breast cancer [Elektronski vir]Tankova, Tsvetalina ...Alpelisib is an α-selective phosphatidylinositol 3-kinase inhibitor used for treating hormone receptor-positive (HR+), human epidermal growth receptor 2-negative (HER2–), PIK3CA-mutated locally ... advanced or metastatic breast cancer following disease progression on or after endocrine therapy. Hyperglycemia is an on-target effect of alpelisib affecting approximately 60% of treated patients, and sometimes necessitating dose reductions, treatment interruptions, or discontinuation of alpelisib. Early detection of hyperglycemia and timely intervention have a key role in achieving optimal glycemic control and maintaining alpelisib dose intensity to optimize the benefit of this drug. A glycemic support program implemented by an endocrinology–oncology collaborative team may be very useful in this regard. Lifestyle modifications, mainly comprising a reduced-carbohydrate diet, and a designated stepwise, personalized antihyperglycemic regimen, based on metformin, sodium–glucose co-transporter 2 inhibitors, and pioglitazone, are the main tools required to address the insulin-resistant hyperglycemia induced by alpelisib. In this report, based on the consensus of 14 oncologists and seven endocrinologists, we provide guidance for hyperglycemia management strategies before, during, and after alpelisib therapy for HR+, HER2–, PIK3CA-mutated breast cancer, with a focus on a proactive, multidisciplinary approach.Source: Cancers [Elektronski vir]. - ISSN 2072-6694 (Vol. 14, no. 7, 2022, str. 1-14)Type of material - e-articlePublish date - 2022Language - englishCOBISS.SI-ID - 101842435
Author
Tankova, Tsvetalina |
Senkus-Konefka, Elżbieta |
Beloyartseva, Maria |
Borštnar, Simona, 1967- |
Catrinoiu, Doina |
Frolova, Mona |
Hegmane, Alinta |
Janež, Andrej, 1971- |
Krnić, Mladen |
Vrdoljak, Eduard
Topics
hiperglikemija |
rak dojke |
metastaski rak |
neželeni učinki |
hyperglycemia |
breast cancer |
metastatic breast cancer |
adverse effect
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|---|
Tankova, Tsvetalina | |
Senkus-Konefka, Elżbieta | |
Beloyartseva, Maria | |
Borštnar, Simona, 1967- | 16303 |
Catrinoiu, Doina | |
Frolova, Mona | |
Hegmane, Alinta | |
Janež, Andrej, 1971- | 18372 |
Krnić, Mladen | |
Vrdoljak, Eduard |
Select pickup location:
Material pickup by post
Notification
Subject headings in COBISS General List of Subject Headings
Select pickup location
Pickup location | Material status | Reservation |
---|
Please wait a moment.